Novo Nordisk’s shares fall sharply after testing of CagriSema falls short of investors’ expectationsBusiness live – latest updatesThe owner of Wegovy and Ozempic has suffered a significant setback, as its highly anticipated new weight-loss treatment was labelled “obsolete” after disappointing clinical trials.Novo Nordisk’s shares fell sharply on Monday after the results from testing the Danish company’s CagriSema drug fell short of investors’ expectations. Continue reading...
Novo Nordisk’s shares fall sharply after testing of CagriSema falls short of investors’ expectations
The owner of Wegovy and Ozempic has suffered a significant setback, as its highly anticipated new weight-loss treatment was labelled “obsolete” after disappointing clinical trials.
Novo Nordisk’s shares fell sharply on Monday after the results from testing the Danish company’s CagriSema drug fell short of investors’ expectations.
Continue reading...
Fund upgrades UK’s GDP growth forecast for 2026 to 1.3%, but says it is likely to ‘edge down’ next year IMF warns global...
It is billing £32.99 a month but I have had no functioning phone line since it switched me to Digital VoiceI’ve had no l...
Some of Britain’s wealthiest financiers, including Sir Paul Marshall, have given a platform to critical coverage or are...
ZyMix platform has contract with Tencent, which US alleges has links to People’s Liberation ArmyA new messaging and paym...
High valuations and debt put sector in danger, while fund also warns on government borrowing and cyber-attacksIMF warns...
Bosses of Citroën owner and French carmaker also urge UK government to consider limiting imports from ChinaStellantis an...
No other articles in this category yet.
